A large grant from a Danish technology fund is to help develop a cancer vaccine and map the human genome.<\/p>\n
This is according to a news release from the University of Copenhagen, that is co-operating with four other universities and three companies on the project.<\/p>\n
The University of Copenhagen, the Technical University of Denmark (DTU), Aarhus University and Aalborg University will co-operate with Bavarian Nordic A\/S, Beijing Genomics Institute Europe A\/S and Genomic Expression ApS, according to the release.<\/p>\n
DKK 86 million from the Danish National Advanced Technology Foundation (H\u00f8jteknologifonden) over five years will contribute to a budget that will total DKK 170 million for the new research centre which will be called the Danish Platform for Large-scale Sequencing and Bioinformatics.<\/p>\n
\u00bbWe want to gather the best bioinformatics and genome researchers in one place in order to create a genome sequencing centre of the highest international standard,\u00ab says University of Copenhagen Prorector Thomas Bj\u00f8rnholm, who led efforts to secure the funding.<\/p>\n
\u00bbOur vision is to create a Danish gene sequencing and bioinformatics facility that will allow us to map Danes\u2019 genes. We hope that it will be possible to identify who is at risk of developing diseases like cancer. One of the goals is to create a vaccine against cancer,\u00ab he says.<\/p>\n
According to the release, the Beijing Genomics Institute, the world\u2019s largest gene sequencing centre, will contribute DKK 60 million to help establish the Copenhagen facility.<\/p>\n
\u00bbThe grant from the Danish National Advanced Technology Foundation makes it possible for BGI Europe to be established in Denmark. This has an enormous impact on disease prevention research and the University\u2019s collaboration with the drug and food industries\u00ab Bj\u00f8rnholm says.<\/p>\n